Open house Trazodone Discount Contracts
Original notice title
Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Trazodon, ATC N06AX05
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No minimum purchase commitment; expected volumes are not disclosed. Revenue from this contract is uncertain.
Contract can be automatically superseded if AOK closes a separate exclusive discount contract for the same substance vi...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Framework procurement
- Supplies contract
- 1 lot
- Duration until May 2027
- Supply of Trazodone (ATC N06AX05) pharmaceutical products under non-exclusive discount agreements.
- Framework agreement with multiple pharmaceutical companies; no exclusivity.
Show full summary
Open-house non-exclusive framework agreement for discount contracts on Trazodone (ATC N06AX05) by AOK Bayern. All qualified pharmaceutical companies may join. No competitive selection; contracts are non-negotiable. Duration 01.06.2025-31.05.2027. Rolling monthly enrollment. No estimated value provided. Eligibility: signed self-declaration of reliability. Submission in paper (2 copies) or electronic with qualified signature. Language: German. No procurement documents analyzed.
Risks
No minimum purchase commitment; expected volumes are not disclosed. Revenue from this contract is uncertain.
Contract can be automatically superseded if AOK closes a separate exclusive discount contract for the same substance vi...
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Eligibility
- Only pharmaceutical companies are eligible.
Administrative
- Submission of signed contract, signed annex listing specific drugs, and signed self-declaration of reliability.
- Documents must be in German (translations required if originally in other languages).
Requirements may be incomplete.
Award Criteria
Lot 1
Buyer
Location
München, DEU
Website
Buyer profile
Identifier
DE811695320
Activity
Health
Lots (1)
LOT-0001
Open house Trazodone Discount Contracts
One lot covering all Trazodone (ATC N06AX05) pharmaceutical products. Non-exclusive framework. All qualified companies can join.
Location
Duration
Category
Award Criteria
Deadline
Award details
No award criteria
this is an open-house model where all qualified participants are accepted.
Value note
Show original TED data
Original lot title
Open house Arzneimittelrabattverträge Trazodon, ATC N06AX05
Original TED description
Siehe kurze Beschreibung ACHTUNG: Die Vertragsunterlagen sind zwingend über den Kommunikationsbereich im Vergabeportal www.dtvp.de einzureichen und keinesfalls über den Angebotsbereich!
Procurement Details
- Publication date
- 15 Apr 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 250553-2025
Documents (2)
Similar tenders
Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)
Denmark – Pharmaceutical products – Amgros 2027 1.1170.a
Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Orylmyte(R) (ATC-Code nach WHO: V01AA03)
Germany – Pharmaceutical products – Open House Biologika Rabattverträge 2026 - 27 - Follitropin delta
Opportunity Score
Why this score?
Opportunity
40 / 100
Complexity
20 / 100
Risk factors
No minimum purchase commitment; expected volumes are not disclosed. Revenue from this contract is uncertain.
Contract can be automatically superseded if AOK closes a separate exclusive discount contract for the same substance vi...
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications